AU2003240997A1 - Complexes for the delivery of biologically-active material to cells - Google Patents

Complexes for the delivery of biologically-active material to cells

Info

Publication number
AU2003240997A1
AU2003240997A1 AU2003240997A AU2003240997A AU2003240997A1 AU 2003240997 A1 AU2003240997 A1 AU 2003240997A1 AU 2003240997 A AU2003240997 A AU 2003240997A AU 2003240997 A AU2003240997 A AU 2003240997A AU 2003240997 A1 AU2003240997 A1 AU 2003240997A1
Authority
AU
Australia
Prior art keywords
biologically
complexes
delivery
cells
active material
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003240997A
Other languages
English (en)
Inventor
Helen Claire Hailes
Stephen Lewis Hart
Christopher Antony Hurley
Alethea Bernice Tabor
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University College London
Original Assignee
University College London
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University College London filed Critical University College London
Publication of AU2003240997A1 publication Critical patent/AU2003240997A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/543—Lipids, e.g. triglycerides; Polyamines, e.g. spermine or spermidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AU2003240997A 2002-05-08 2003-05-08 Complexes for the delivery of biologically-active material to cells Abandoned AU2003240997A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0210538.5 2002-05-08
GBGB0210538.5A GB0210538D0 (en) 2002-05-08 2002-05-08 Lipids and gene delivery
PCT/GB2003/001985 WO2003094974A1 (en) 2002-05-08 2003-05-08 Complexes for the delivery of biologically-active material to cells

Publications (1)

Publication Number Publication Date
AU2003240997A1 true AU2003240997A1 (en) 2003-11-11

Family

ID=9936285

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003240997A Abandoned AU2003240997A1 (en) 2002-05-08 2003-05-08 Complexes for the delivery of biologically-active material to cells

Country Status (5)

Country Link
EP (1) EP1506019A1 (enExample)
JP (1) JP2005530771A (enExample)
AU (1) AU2003240997A1 (enExample)
GB (1) GB0210538D0 (enExample)
WO (1) WO2003094974A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0313132D0 (en) 2003-06-06 2003-07-09 Ich Productions Ltd Peptide ligands
WO2005117985A2 (en) * 2004-06-02 2005-12-15 Ucl Biomedica Plc Lipopolyplex construct with an integrin binding peptide for delivery of nucleic acids, peptides or drugs
DK2355851T3 (en) 2008-11-10 2018-06-25 Arbutus Biopharma Corp Newly known lipids and compositions for release of therapeutic agents
EP4207205A4 (en) * 2020-08-31 2025-02-26 Takeda Pharmaceutical Company Limited Inference device, inference method, inference program, model generating method, inference service providing system, inference service providing method, and inference service providing program

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5527928A (en) * 1994-09-30 1996-06-18 Nantz; Michael H. Cationic transport reagents
ES2299232T3 (es) * 1995-09-11 2008-05-16 La Jolla Cancer Research Foundation Moleculas que migran hacia un organo o tejido seleccionado in vivo.
US5869715A (en) * 1995-09-27 1999-02-09 The Reagents Of The University Of California Polyfunctional cationic cytofectins
AU7078396A (en) * 1995-09-27 1997-04-30 Regents Of The University Of California, The Polyfunctional cationic cytofectins, formulations and methods for generating active cytofectin:polynucleotide transfection complexes
GB9711115D0 (en) * 1997-05-29 1997-07-23 Inst Of Child Health Integrin-targeting vectors having enhanced transfection activity
JP4800485B2 (ja) * 1999-03-26 2011-10-26 バイカル インコーポレイテッド ポリヌクレオチドベースのワクチンに対する免疫応答を増強するためのアジュバント組成物および方法
CA2375727C (en) * 1999-05-28 2010-05-25 Vical Incorporated Cytofectin dimers and methods of use thereof

Also Published As

Publication number Publication date
GB0210538D0 (en) 2002-06-19
EP1506019A1 (en) 2005-02-16
WO2003094974A1 (en) 2003-11-20
JP2005530771A (ja) 2005-10-13

Similar Documents

Publication Publication Date Title
EP1513538A4 (en) Novel methods for introducing polynucleotides into cells
AU2003220914A1 (en) Shield material
AU2003227669A1 (en) Photocurable compositions containing reactive particles
AU2003291103A1 (en) Pharmaceutical composition
AU2003290734A1 (en) Novel compounds as pharmaceutical agents
AU2002329877A1 (en) Cross reference to related art
AU2003901668A0 (en) Non-haemopoietic precursor cells
AU2003301405A1 (en) Prepolymeric materials for site specific delivery to the body
AU2003278393A1 (en) New use for pharmaceutical composition
AU2003272069A1 (en) Novel floating dosage form
AU2003250372A1 (en) Pharmaceutical composition
AU2003234909A1 (en) Powder composition
AU2003220273A1 (en) Bulk material pump feeder
AU2003201826A1 (en) Compounds for delivering substances into cells
EP1542609B8 (en) Pharmaceutical compositions comprising Interferon beta for use in treating melanoma
AU2003282722A1 (en) Therapeutic compositions
AU2003233966A1 (en) Analogous compounds of strobilurines and their use as acaricides and insecticides
AU2003278849A1 (en) Process for dry milling zinc powder to produce zinc flake
AU2003240997A1 (en) Complexes for the delivery of biologically-active material to cells
GB0610636D0 (en) Materials and complexes for the delivery of biologically-active material to cells
AU2003284460A1 (en) Medicinal composition
AU2003291642A1 (en) Pyrazoloazepine compounds as pharmaceutical agents
AU2003216503A1 (en) Stable pharmaceutical compositions
AUPS225402A0 (en) Modified cell production
AU2003302320A1 (en) Seterocyclic quinones as pharmaceutical agents

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase
TH Corrigenda

Free format text: IN VOL 18, NO 2, PAGE(S) 606 UNDER THE HEADING APPLICATIONS OPI - NAME INDEX UNDER THE NAME UNIVERSITY COLLEGE LONDON, APPLICATION NO. 2003240997, UNDER INID (43) CORRECT THE PUBLICATION DATE TO READ 24.11.2003